Literature DB >> 21112256

Role of senataxin in DNA damage and telomeric stability.

Andrea De Amicis1, Maria Piane, Francesca Ferrari, Maurizio Fanciulli, Domenico Delia, Luciana Chessa.   

Abstract

Ataxia with oculomotor apraxia type 2 (AOA2) is an autosomal recessive neurodegenerative disorder characterized by cerebellar ataxia and oculomotor apraxia. The gene mutated in AOA2, SETX, encodes senataxin (SETX), a putative DNA/RNA helicase. The presence of the helicase domain led us to investigate whether SETX might play a role in DNA damage repair and telomere stability. We analyzed the response of AOA2 lymphocytes and lymphoblasts after treatment with camptothecin (CPT), mitomycin C (MMC), H₂O₂ and X-rays by cytogenetic and Q-FISH (quantitative-FISH) assays. The rate of chromosomal aberrations was normal in AOA2 cells after treatment with CPT, MMC, H₂O₂ and X-rays. Conversely, Q-FISH analysis showed constitutively reduced telomere length in AOA2 lymphocytes, compared to age-matched controls. Furthermore, CPT- or X-ray-induced telomere shortening was more marked in AOA2 than in control cells. The partial co-localization of SETX with telomeric DNA, demonstrated by combined immunofluorescence-Q-FISH and chromatin immunoprecipitation, suggests a possible involvement of SETX in telomere stability.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21112256     DOI: 10.1016/j.dnarep.2010.10.012

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  18 in total

Review 1.  Termination of Transcription of Short Noncoding RNAs by RNA Polymerase II.

Authors:  Karen M Arndt; Daniel Reines
Journal:  Annu Rev Biochem       Date:  2015-03-26       Impact factor: 23.643

2.  Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2).

Authors:  Olivier J Becherel; Brent L Fogel; Scott I Zeitlin; Hemamali Samaratunga; Jessica Greaney; Hayden Homer; Martin F Lavin
Journal:  Cerebellum       Date:  2019-06       Impact factor: 3.847

3.  Novel mutations in ataxia telangiectasia and AOA2 associated with prolonged survival.

Authors:  Marie Y Davis; C Dirk Keene; Phillip D Swanson; Conor Sheehy; Thomas D Bird
Journal:  J Neurol Sci       Date:  2013-09-17       Impact factor: 3.181

Review 4.  R Loops and Links to Human Disease.

Authors:  Patricia Richard; James L Manley
Journal:  J Mol Biol       Date:  2016-09-04       Impact factor: 5.469

Review 5.  DNA repair abnormalities leading to ataxia: shared neurological phenotypes and risk factors.

Authors:  Edward C Gilmore
Journal:  Neurogenetics       Date:  2014-07-20       Impact factor: 2.660

6.  A new model to study neurodegeneration in ataxia oculomotor apraxia type 2.

Authors:  Olivier J Becherel; Jane Sun; Abrey J Yeo; Sam Nayler; Brent L Fogel; Fuying Gao; Giovanni Coppola; Chiara Criscuolo; Giuseppe De Michele; Ernst Wolvetang; Martin F Lavin
Journal:  Hum Mol Genet       Date:  2015-07-30       Impact factor: 6.150

7.  Evidence of synergism among three genetic variants in a patient with LMNA-related lipodystrophy and amyotrophic lateral sclerosis leading to a remarkable nuclear phenotype.

Authors:  Kathryn Volkening; Sali M K Farhan; Jessica Kao; Cheryl Leystra-Lantz; Lee Cyn Ang; Adam McIntyre; Jian Wang; Robert A Hegele; Michael J Strong
Journal:  Mol Cell Biochem       Date:  2021-03-04       Impact factor: 3.396

Review 8.  Out of balance: R-loops in human disease.

Authors:  Matthias Groh; Natalia Gromak
Journal:  PLoS Genet       Date:  2014-09-18       Impact factor: 5.917

9.  Senataxin protects the genome: Implications for neurodegeneration and other abnormalities.

Authors:  Martin F Lavin; Abrey J Yeo; Olivier J Becherel
Journal:  Rare Dis       Date:  2013-06-06

10.  Protein interaction analysis of senataxin and the ALS4 L389S mutant yields insights into senataxin post-translational modification and uncovers mutant-specific binding with a brain cytoplasmic RNA-encoded peptide.

Authors:  Craig L Bennett; Yingzhang Chen; Marissa Vignali; Russell S Lo; Amanda G Mason; Asli Unal; Nabiha P Huq Saifee; Stanley Fields; Albert R La Spada
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.